DexCom Inc (NAS:DXCM)
$ 130.18 0.47 (0.36%) Market Cap: 51.77 Bil Enterprise Value: 51.32 Bil PE Ratio: 83.99 PB Ratio: 22.96 GF Score: 89/100

Dexcom Inc at Citi Healthcare & Medtech Conference Transcript

Mar 01, 2023 / 07:45PM GMT
Release Date Price: $110.76 (-0.23%)
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

Hello. Everybody, hello. We are here for the afternoon session. This one is Dexcom, so it's where you want to be. Very pleased to have Sean Christensen with us. And in the front row is Matt Carey. He also has a variety of show and tell devices, the G7, the G6, the G5 and the applicator. So I think there is a difference. But anyway, thank you for joining us today.

Questions & Answers

Joanne Karen Wuensch
Citigroup Inc., Research Division - MD

I want to start with sort of a big picture question, which really has to do with -- so I hear you have this new device, and there was like this big football game that was advertised on. Can you catch us up on the G7 launch and the early feedback? And you may not know this, but there was a doctor right here a couple of hours ago who was saying that after that app, his phone lit up and his contacts went up.

Sean Christensen
DexCom, Inc. - Director of Corporate Affairs & Head of IR

That's great. Thanks for

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot